EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS
Publication
, Conference
Bernard, AL; Friedlander, HS; White, E; Raburn, D; Neal, S; Acharya, KS
Published in: FERTILITY AND STERILITY
2024
Duke Scholars
Published In
FERTILITY AND STERILITY
EISSN
1556-5653
ISSN
0015-0282
Publication Date
2024
Volume
122
Issue
4
Start / End Page
E126 / E127
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine
- 1117 Public Health and Health Services
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bernard, A. L., Friedlander, H. S., White, E., Raburn, D., Neal, S., & Acharya, K. S. (2024). EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS. In FERTILITY AND STERILITY (Vol. 122, pp. E126–E127).
Bernard, Abigail L., Hilary S. Friedlander, Erin White, Douglas Raburn, Shelby Neal, and Kelly S. Acharya. “EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS.” In FERTILITY AND STERILITY, 122:E126–27, 2024.
Bernard AL, Friedlander HS, White E, Raburn D, Neal S, Acharya KS. EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS. In: FERTILITY AND STERILITY. 2024. p. E126–7.
Bernard, Abigail L., et al. “EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS.” FERTILITY AND STERILITY, vol. 122, no. 4, 2024, pp. E126–27.
Bernard AL, Friedlander HS, White E, Raburn D, Neal S, Acharya KS. EFFECTOFABORTION LEGISLATION ON ELECTIVE UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN LOW-RISK PATIENTS, INCLUDING DONOR OOCYTE RECIPIENTS. FERTILITY AND STERILITY. 2024. p. E126–E127.
Published In
FERTILITY AND STERILITY
EISSN
1556-5653
ISSN
0015-0282
Publication Date
2024
Volume
122
Issue
4
Start / End Page
E126 / E127
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine
- 1117 Public Health and Health Services
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences